Duality Biotherapeutics Schedules 28 Aug 2026 Board Meeting to Review 1H 2026 Unaudited Results

Bulletin Express08-14

Duality Biotherapeutics, Inc. (ticker: DUALITYBIO-B) has announced that its board of directors will convene on 28 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. The meeting will also address matters related to the public release of the interim report.

The board currently consists of eight members, including Executive Directors Dr. Zhu Zhongyuan (Chairman and CEO), Mr. Zhang Shaoren, and Dr. Hua Haiqing; Non-Executive Directors Mr. Cai Zhiyang and Dr. Yu Tao; and Independent Non-Executive Directors Mr. Xie Dong, Mr. Gao Fengyong, and Ms. Chuai Shuyin.

The company affirmed that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the announcement’s contents.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156090062?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156090062","market":"hk","top_or_hot":-1,"title":"Duality Biotherapeutics Schedules 28 Aug 2026 Board Meeting to Review 1H 2026 Unaudited Results","media":"Bulletin Express","content":"<p>Duality Biotherapeutics, Inc. (ticker: DUALITYBIO-B) has announced that its board of directors will convene on 28 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. The meeting will also address matters related to the public release of the interim report.</p>\n<p>The board currently consists of eight members, including Executive Directors Dr. Zhu Zhongyuan (Chairman and CEO), Mr. Zhang Shaoren, and Dr. Hua Haiqing; Non-Executive Directors Mr. Cai Zhiyang and Dr. Yu Tao; and Independent Non-Executive Directors Mr. Xie Dong, Mr. Gao Fengyong, and Ms. Chuai Shuyin.</p>\n<p>The company affirmed that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the announcement’s contents.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Duality Biotherapeutics Schedules 28 Aug 2026 Board Meeting to Review 1H 2026 Unaudited Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDuality Biotherapeutics Schedules 28 Aug 2026 Board Meeting to Review 1H 2026 Unaudited Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Duality Biotherapeutics, Inc. (ticker: DUALITYBIO-B) has announced that its board of directors will convene on 28 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. The meeting will also address matters related to the public release of the interim report.</p>\n<p>The board currently consists of eight members, including Executive Directors Dr. Zhu Zhongyuan (Chairman and CEO), Mr. Zhang Shaoren, and Dr. Hua Haiqing; Non-Executive Directors Mr. Cai Zhiyang and Dr. Yu Tao; and Independent Non-Executive Directors Mr. Xie Dong, Mr. Gao Fengyong, and Ms. Chuai Shuyin.</p>\n<p>The company affirmed that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the announcement’s contents.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09606","symbol_name":"映恩生物-B","start_time":0,"source_url":"","article_id":"1156090062","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156090062","pubTimestamp":1786697272,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Duality Biotherapeutics, Inc. (ticker: DUALITYBIO-B) has announced that its board of directors will convene on 28 August 2026 to consider and approve the unaudited financial results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09606":"映恩生物-B"},"translate_title":"Duality Biotherapeutics 计划于 2026 年 8 月 28 日召开董事会会议，审查 2026 年上半年未经审计的业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09606":1},"content_text":"Duality Biotherapeutics, Inc. (ticker: DUALITYBIO-B) has announced that its board of directors will convene on 28 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. The meeting will also address matters related to the public release of the interim report.\nThe board currently consists of eight members, including Executive Directors Dr. Zhu Zhongyuan (Chairman and CEO), Mr. Zhang Shaoren, and Dr. Hua Haiqing; Non-Executive Directors Mr. Cai Zhiyang and Dr. Yu Tao; and Independent Non-Executive Directors Mr. Xie Dong, Mr. Gao Fengyong, and Ms. Chuai Shuyin.\nThe company affirmed that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the announcement’s contents.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156090062","isCrawlerRequest":true}